IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing

Liquid biopsy testing is a new laboratory-based method that detects tumour mutations in circulating free DNA (cfDNA) derived from minimally invasive blood sampling techniques. Recognising the significance for clinical testing, in 2017, IQN Path provided external quality assessment for liquid biopsy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Virchows Arch
Main Authors: Deans, Zandra C., Butler, Rachel, Cheetham, Melanie, Dequeker, Elisabeth M. C., Fairley, Jennifer A., Fenizia, Francesca, Hall, Jacqueline A., Keppens, Cleo, Normanno, Nicola, Schuuring, Ed, Patton, Simon J.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581928/
https://ncbi.nlm.nih.gov/pubmed/31028539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-019-02571-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados